AgingResearch.NewsJoin free

Cytomegalovirus seropositivity

Cytomegalovirus seropositivity has been studied in 2 papers since 2017: 2 observational studies in people. The newest paper, Jun 1, 2023: “Age-related Differences in T-cell Subsets and Markers of Subclinical Inflammation in Aging Are Independently Associated With Type 2 Diabetes in the Health and Retirement Study”.

Exposure

2 papers study it1 findingUpdated

See all 2

“In contrast, CMV serostatus had no significant impact on absolute numbers of mDC and monocytes.”
Distinct effect of age, sex, and CMV seropositivity on dendritic cells and monocytes in human bloodImmunology and cell biology2017doi:10.1111/imcb.1004

C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

  • 1 lab in 1 country
  • Funder: Conseil Régional Midi-Pyrénées
  • Humans2

What did studies of Cytomegalovirus seropositivity find?

1

Studies of Cytomegalovirus seropositivity measured 1 outcome; the most studied are myeloid dendritic cell and monocyte counts (1 study).

Myeloid dendritic cell and monocyte counts

no changein humans1

1 study

  1. Cytomegalovirus seropositivity has no effect on myeloid dendritic cell and monocyte counts in humans.

    “In contrast, CMV serostatus had no significant impact on absolute numbers of mDC and monocytes.”

    Humanshealthy individualswhole bloodn = 256

    Distinct effect of age, sex, and CMV seropositivity on dendritic cells and monocytes in human blood

    Immunology and cell biology

More on Myeloid dendritic cell and monocyte counts

Latest

Related